Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anal Dysplasia Study in HIV+ MSM
NCT01663558Phase 4Withdrawn
- Sponsor
- Naval Medical Center San Diego
- Start
- May 2015
- Primary completion
- Dec 2015
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of imiquimod in anal dysplasia, sponsored by Naval Medical Center San Diego. Planned start May 2015; status: withdrawn.
02
Drugs
imiquimod
03
Conditions
anal dysplasia
Beyond the preview
Go deeper on NCT01663558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01663558.